Unlocking the future of neurodegeneration research: How auto...

On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.

When costing and compliance collide

Only a few years ago, compliance was the undisputed top priority in the pharmaceutical industry - regardless of cost.

‘Show me the molecule’ – On synthetic biology and cutting th...